Retatrutide Peptide – Triple G Weight Loss
What is retatrutide? Eli Lilly's investigational triple-hormone receptor agonist (GLP-1, GIP, glucagon) delivered up to 30.3% mean weight loss in Phase 3 TRIUMPH-1. FDA filing expected early 2027.
1 article with this tag.
What is retatrutide? Eli Lilly's investigational triple-hormone receptor agonist (GLP-1, GIP, glucagon) delivered up to 30.3% mean weight loss in Phase 3 TRIUMPH-1. FDA filing expected early 2027.